• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用表达HIV-1 Gag的痘苗免疫BALB/c小鼠所鉴定出的T细胞表位位于HIV感染的印度患者所识别的免疫显性区域内。

T-cell Epitopes Identified by BALB/c Mice Immunized with Vaccinia Expressing HIV-1 Gag lie within immunodominant Regions Recognized by HIV-infected Indian Patients.

作者信息

Shete Ashwini V, Thakar Madhuri R, Tripathy Srikanth P, Raut Cg, Chakrabarti Sekhar, Paranjape Ramesh S

机构信息

Department of Immunology and Molecular Virology, Pune, India.

出版信息

J Glob Infect Dis. 2011 Jul;3(3):246-53. doi: 10.4103/0974-777X.83530.

DOI:10.4103/0974-777X.83530
PMID:21887056
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3162811/
Abstract

BACKGROUND

Human immunodeficiency virus (HIV) antigens from transmitted strains of HIV would prove crucial in vaccine designing for prevention of HIV infection. Immune response generated by Vaccinia construct expressing the HIV-1 gag gene from transmitted Indian HIV-1 subtype C strain (Vgag) in BALB/c mice is reported in the present study along with the identification of epitopes responsible for induction of the immune response.

AIMS

The aim of this study was to determine immune response generated by the constructs in a mouse model and to understand the epitope specificities of the response.

SETTINGS AND DESIGN

This was an observational study carried out in BALB/c mice.

MATERIALS AND METHODS

The immunogenecity of Vgag construct was evaluated in BALB/c mice after multiple immunizations. T-cell response was monitored by the interferon-γ ELISPOT assay using HIV-1 C Gag overlapping peptides and anti-P24 antibodies were estimated by ELISA.

STATISTICAL ANALYSIS USED

Graphpad prism software was used for statistical analysis and for plotting graphs.

RESULTS

IFN-γ-secreting T cells and antibodies were detected against HIV Gag in mice after immunization. Although after repeated immunizations, antibody-mediated immune response increased or remained sustained, the magnitude of IFN-γ-secreting T cell was found to be decreased over time. The Gag peptides recognized by mice were mainly confined to the P24 region and had a considerable overlap with earlier reported immunodominant regions recognized by HIV-infected Indian patients.

CONCLUSION

Vaccinia construct with a gag gene from transmitted HIV-1 virus was found to be immunogenic. The Gag regions identified by mice could have important implications in terms of future HIV vaccine designing.

摘要

背景

来自HIV传播毒株的人类免疫缺陷病毒(HIV)抗原对于预防HIV感染的疫苗设计至关重要。本研究报告了在BALB/c小鼠中由表达来自印度HIV-1 C亚型传播毒株的HIV-1 gag基因的痘苗构建体(Vgag)产生的免疫反应,同时鉴定了负责诱导免疫反应的表位。

目的

本研究的目的是确定构建体在小鼠模型中产生的免疫反应,并了解该反应的表位特异性。

设置与设计

这是一项在BALB/c小鼠中进行的观察性研究。

材料与方法

多次免疫后,在BALB/c小鼠中评估Vgag构建体的免疫原性。使用HIV-1 C Gag重叠肽通过干扰素-γ ELISPOT试验监测T细胞反应,并通过ELISA估计抗P24抗体。

所用统计分析

使用Graphpad prism软件进行统计分析和绘制图表。

结果

免疫后在小鼠中检测到针对HIV Gag的分泌干扰素-γ的T细胞和抗体。尽管多次免疫后,抗体介导的免疫反应增加或持续存在,但发现分泌干扰素-γ的T细胞数量随时间减少。小鼠识别的Gag肽主要局限于P24区域,并且与先前报道的HIV感染的印度患者识别的免疫显性区域有相当大的重叠。

结论

发现带有来自传播的HIV-1病毒gag基因的痘苗构建体具有免疫原性。小鼠识别的Gag区域可能对未来的HIV疫苗设计具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca3/3162811/30e3b8d79b92/JGID-3-246-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca3/3162811/e0679b7c0d06/JGID-3-246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca3/3162811/424f900d5206/JGID-3-246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca3/3162811/2b23d71a4399/JGID-3-246-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca3/3162811/44df1f11220e/JGID-3-246-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca3/3162811/30e3b8d79b92/JGID-3-246-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca3/3162811/e0679b7c0d06/JGID-3-246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca3/3162811/424f900d5206/JGID-3-246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca3/3162811/2b23d71a4399/JGID-3-246-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca3/3162811/44df1f11220e/JGID-3-246-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca3/3162811/30e3b8d79b92/JGID-3-246-g005.jpg

相似文献

1
T-cell Epitopes Identified by BALB/c Mice Immunized with Vaccinia Expressing HIV-1 Gag lie within immunodominant Regions Recognized by HIV-infected Indian Patients.用表达HIV-1 Gag的痘苗免疫BALB/c小鼠所鉴定出的T细胞表位位于HIV感染的印度患者所识别的免疫显性区域内。
J Glob Infect Dis. 2011 Jul;3(3):246-53. doi: 10.4103/0974-777X.83530.
2
Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.来自感染HIV-1 C亚型的印度患者的细胞毒性T淋巴细胞(CTL)识别来自HIV-1 Gag和Nef保守免疫显性区域的CTL表位。
J Infect Dis. 2005 Sep 1;192(5):749-59. doi: 10.1086/432547. Epub 2005 Jul 27.
3
[Peptide mapping of H-2d restricted T-cell epitope against six antigens of HIV-1 subtype B'/C by ELISPOT assay].[通过酶联免疫斑点分析对H-2d限制性T细胞表位针对HIV-1 B'/C亚型六种抗原的肽图谱分析]
Bing Du Xue Bao. 2011 Jan;27(1):34-43.
4
Immunogenicity of recombinant Modified Vaccinia Ankara Viruses (rMVA) expressing HIV-1 Indian subtype C gag-protease and env-gp120 genes in mice.表达HIV-1印度C亚型gag蛋白酶和env-gp120基因的重组改良安卡拉痘苗病毒(rMVA)在小鼠中的免疫原性
Viral Immunol. 2004;17(4):574-9. doi: 10.1089/vim.2004.17.574.
5
Induction of broad-based immune response against HIV-1 subtype C gag DNA vaccine in mice.
Viral Immunol. 2004;17(3):423-35. doi: 10.1089/vim.2004.17.423.
6
Mucosal Priming with a Recombinant Influenza A Virus-Vectored Vaccine Elicits T-Cell and Antibody Responses to HIV-1 in Mice.黏膜佐剂增强的重组流感病毒载体疫苗在小鼠中诱导针对 HIV-1 的 T 细胞和抗体应答。
J Virol. 2021 May 24;95(12). doi: 10.1128/JVI.00059-21.
7
Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.基于具有复制能力的弹状病毒疫苗载体表达的1型人类免疫缺陷病毒Gag的表达及免疫原性
J Virol. 2001 Sep;75(18):8724-32. doi: 10.1128/jvi.75.18.8724-8732.2001.
8
Cross-Reactive Potential of HIV-1 Subtype C-Infected Indian Individuals Against Multiple HIV-1 Potential T Cell Epitope Gag Variants.HIV-1 C亚型感染的印度个体对多种HIV-1潜在T细胞表位Gag变体的交叉反应潜力
Viral Immunol. 2016 Dec;29(10):572-582. doi: 10.1089/vim.2016.0060. Epub 2016 Nov 22.
9
CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.肯尼亚A亚型感染个体中HIV-1的Gag和Nef蛋白的CTL表位分布模式:使用多种肽组可增加CTL反应的可检测广度。
BMC Immunol. 2006 Apr 18;7:8. doi: 10.1186/1471-2172-7-8.
10
Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection.慢性未经治疗的C型HIV-1感染中免疫显性的HIV-1 CD4+ T细胞表位
PLoS One. 2009;4(4):e5013. doi: 10.1371/journal.pone.0005013. Epub 2009 Apr 7.

引用本文的文献

1
Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteers.DNA 和 MVA HIV-1 亚型 C 疫苗初免-加强免疫方案的安全性和免疫原性:在 HIV 未感染者印度志愿者中进行的 I 期随机试验。
PLoS One. 2013;8(2):e55831. doi: 10.1371/journal.pone.0055831. Epub 2013 Feb 13.

本文引用的文献

1
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.在泰国使用ALVAC和AIDSVAX疫苗预防HIV-1感染。
N Engl J Med. 2009 Dec 3;361(23):2209-20. doi: 10.1056/NEJMoa0908492. Epub 2009 Oct 20.
2
Blood and seminal plasma HIV-1 RNA levels among HIV-1-infected injecting drug users participating in the AIDSVAX B/E efficacy trial in Bangkok, Thailand.参与泰国曼谷AIDSVAX B/E疗效试验的HIV-1感染注射吸毒者的血液和精液血浆HIV-1 RNA水平。
J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):601-8. doi: 10.1097/QAI.0b013e3181a44700.
3
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.
一种细胞介导免疫HIV-1疫苗的疗效评估(STEP研究):一项双盲、随机、安慰剂对照的概念验证试验。
Lancet. 2008 Nov 29;372(9653):1881-1893. doi: 10.1016/S0140-6736(08)61591-3. Epub 2008 Nov 13.
4
Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses.通过新城疫病毒载体优化人类免疫缺陷病毒gag表达以诱导强效免疫反应。
J Virol. 2009 Jan;83(2):584-97. doi: 10.1128/JVI.01443-08. Epub 2008 Nov 12.
5
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice.在BALB/c小鼠中鉴定新的HIV-1 Gag特异性细胞毒性T淋巴细胞反应。
Virol J. 2008 Jul 14;5:81. doi: 10.1186/1743-422X-5-81.
6
Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads.广泛且偏向 gag 的 HIV-1 表位库与较低的病毒载量相关。
PLoS One. 2008 Jan 9;3(1):e1424. doi: 10.1371/journal.pone.0001424.
7
Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression.针对gag的CD8 + T淋巴细胞在艾滋病病毒整合和病毒蛋白表达之前就能识别被感染的细胞。
J Immunol. 2007 Mar 1;178(5):2746-54. doi: 10.4049/jimmunol.178.5.2746.
8
Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines.美国国立卫生研究院疫苗研究中心针对人类免疫缺陷病毒/艾滋病候选疫苗开展的1期临床试验。
J Infect Dis. 2006 Dec 15;194(12):1625-7. doi: 10.1086/509263. Epub 2006 Nov 8.
9
Analysis of HIV type 1 subtype C full-length gag gene sequences from India: novel observations and plausible implications.
AIDS Res Hum Retroviruses. 2005 Dec;21(12):1066-72. doi: 10.1089/aid.2005.21.1066.
10
Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.1型人类免疫缺陷病毒非B亚型(A至G)感染者对gag的广泛跨分支T细胞反应:HLA锚定残基保守性的重要性
J Virol. 2005 Sep;79(17):11247-58. doi: 10.1128/JVI.79.17.11247-11258.2005.